Market Place
Sourcing Support
Biorestorative Therapies Showcases Ongoing Phase 2 Trial Data
30 Apr 2026 //
GLOBENEWSWIRE
BioRestorative Reports Positive Phase 2 BRTX-100 Data
30 Mar 2026 //
GLOBENEWSWIRE
BioRestorative Unveils Positive BRTX-100 Phase 2 Data
19 Mar 2026 //
GLOBENEWSWIRE
Biorestorative Therapies Issues Shareholder Letter On Milestones
04 Mar 2026 //
GLOBENEWSWIRE
BioRestorative Bolsters Global IP Portfolio for ThermoStem
24 Feb 2026 //
GLOBENEWSWIRE
Biorestorative Finishes Phase 2 Trial Enrollment For BRTX-100
10 Feb 2026 //
GLOBENEWSWIRE
FDA Grants Type B Meeting for BioRestorative`s BRTX-100 BLA
17 Nov 2025 //
GLOBENEWSWIRE
Biorestorative Therapies Reveals Q3 2025 Financials & Business
12 Nov 2025 //
GLOBENEWSWIRE
Biorestorative Therapies To Release Q3 2025 Financials Result
05 Nov 2025 //
GLOBENEWSWIRE
BioRestorative Awarded Notice of Allowance for Japanese Patent
27 Oct 2025 //
GLOBENEWSWIRE
BioRestorative to Discuss BRTX-100 Clinical Data at Benzinga Show
18 Jun 2025 //
GLOBENEWSWIRE
BioRestorative Unveils Positive BRTX-100 Lumbar Pain Data
13 Jun 2025 //
GLOBENEWSWIRE
BioRestorative to Present Phase 2 BRTX-100 Data at ISSCR 2025
09 Jun 2025 //
GLOBENEWSWIRE
BRTX-100 Phase 2 Trial in cLDD Shows Positive Preliminary Data
13 May 2025 //
GLOBENEWSWIRE
BioRestorative: No Impact from Tariffs; BRTX-100 Made in US
10 Apr 2025 //
GLOBENEWSWIRE
BioRestorative Reports 2024 Financial Results & Business Update
27 Mar 2025 //
GLOBENEWSWIRE
BioRestorative to Report 2024 Financials, Host Call on March 27
20 Mar 2025 //
GLOBENEWSWIRE
BioRestorative gets FDA clearance for BRTX-100 Phase 2 trial
27 Feb 2025 //
GLOBENEWSWIRE
BioRestorative to Update FDA on Clinical Pipeline
25 Feb 2025 //
GLOBENEWSWIRE
BioRestorative Gains FDA Fast Track For BRTX-100 In Lumbar Disc
20 Feb 2025 //
GLOBENEWSWIRE
BRTX-100 Front and Center at ORS 2025
10 Feb 2025 //
GLOBENEWSWIRE
BioRestorative Reports Positive Phase 2 BRTX-100 Data
13 Nov 2024 //
GLOBENEWSWIRE
BioRestorative Therapies to Present Clinical Data at PSRS Symposium
06 Nov 2024 //
GLOBENEWSWIRE
BioRestorative Receives Expanded Tissue License from NY Health Dept
05 Nov 2024 //
GLOBENEWSWIRE
BioRestorative Participate UBS And Maxim Group Investor Events
10 Oct 2024 //
GLOBENEWSWIRE
BioRestorative To Join 3rd Annual ROTH Healthcare Opportunities Conf
03 Oct 2024 //
GLOBENEWSWIRE
BioRestorative Therapies To Present ThermoStem® At IFATS 2024
19 Sep 2024 //
GLOBENEWSWIRE
BioRestorative Therapies Reports Q2 2024 Results And Business Update
13 Aug 2024 //
GLOBENEWSWIRE
BioRestorative Therapies To Report Q2 2024 Results On August 13
06 Aug 2024 //
GLOBENEWSWIRE
BioRestorative Exosome Therapy For Obesity Program
08 May 2024 //
GLOBENEWSWIRE
BioRestorative Receives FDA Clearance for BRTX-100 Phase 2 Protocol Amendment
16 Apr 2024 //
GLOBENEWSWIRE
BioRestorative Partners with Galen for Ph 2 Trial of BRTX-100
08 Apr 2024 //
GLOBENEWSWIRE
BioRestorative Enters into Supply Agreement with Evolutionary Biologics
12 Sep 2023 //
GLOBENEWSWIRE
BioRestorative Therapies Receives Landmark License From New York State
21 Jul 2023 //
ACCESSWIRE
BioRestorative Therapies` Drug Candidate BRTX-100 Passes Safety Test
07 Jul 2023 //
ACCESSWIRE
BioRestorative Therapies Announces Completion of Patient its Ph2 of BRTX-100
24 Apr 2023 //
GLOBENEWSWIRE
BioRestorative to Seek FDA Approval to Expand the Application of BRTX-100
13 Mar 2023 //
GLOBENEWSWIRE
